DETAILED NOTES ON SUVOREXANT

mavorixafor will boost the degree or influence of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Keep an eye on for adverse outcomes of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).darifenacin will increase the amount or outcome of triazolam by affecting hepatic/int